Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
S01GX06
CAS registry number (Chemical Abstracts Service)
0087233-61-2
Chemical Formula
C17-H26-N4-O
Molecular Weight
302
Therapeutic Categories
Antiallergic agent
Histamine, H₁-receptor antagonist
Chemical Name
1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole
Foreign Names
- Emedastinum (Latin)
- Emedastin (German)
- Émédastine (French)
- Emedastina (Spanish)
Generic Names
- Emedastine (OS: BAN)
- Émédastine (OS: DCF)
- Emedastine Difumarate (OS: USAN, JAN)
- Emedastine Fumarate (OS: BANM)
- AL 3432 (IS: Kanebo)
- KB 2413 (IS: Kanebo)
- LY 188695 (IS: Lilly)
- Emedastine Difumarate (PH: Ph. Eur. 6, USP 32)
- Emedastine Fumarate (PH: BP 2010)
- Emedastini difumaras (PH: Ph. Eur. 6)
Brand Names
- Emadine
Alcon, Bulgaria; Alcon, Bulgaria; Alcon, China; Alcon, Spain; Alcon, Serbia; Alcon, Tunisia - Daren
Organon, Japan - Emadine
Alcon, Austria; Alcon, Bangladesh; Alcon, Bahrain; Alcon, Canada; Alcon, Switzerland; Alcon, Czech Republic; Alcon, Germany; Alcon, Finland; Alcon, United Kingdom; Alcon, Georgia; Alcon, Greece; Alcon, Hong Kong; Alcon, Hungary; Alcon, Ireland; Alcon, Israel; Alcon, Iceland; Alcon, Italy; Alcon, Luxembourg; Alcon, Netherlands; Alcon, Norway; Alcon, Oman; Alcon, Portugal; Alcon, Romania; Alcon, Sweden; Alcon, Slovenia; Alcon, Slovakia; Alcon, Taiwan; Alcon, United States; Alcon, South Africa; Alcon-Couvreur, Belgium; Liba, Turkey; Alcon Laboratories Inc.US, Denmark - Emeromin
Towa Yakuhin, Japan - Remicut
Kowa Souyaku, Japan
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment